Twenty-year trajectories of cardio-metabolic factors among people with type 2 diabetes by dementia status in England: a retrospective cohort study.
Blood pressure
Body mass index
Cardio-metabolic risk factors
Cholesterol
Cohort
Dementia
Glucose
Haemoglobin A1c
High-density lipoprotein
Longitudinal
Low-density lipoprotein
Predictors
Trajectories
Type 2 diabetes
Vascular risk factors
Journal
European journal of epidemiology
ISSN: 1573-7284
Titre abrégé: Eur J Epidemiol
Pays: Netherlands
ID NLM: 8508062
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
received:
24
06
2022
accepted:
17
02
2023
medline:
19
6
2023
pubmed:
5
3
2023
entrez:
4
3
2023
Statut:
ppublish
Résumé
To assess 20-year retrospective trajectories of cardio-metabolic factors preceding dementia diagnosis among people with type 2 diabetes (T2D). We identified 227,145 people with T2D aged > 42 years between 1999 and 2018. Annual mean levels of eight routinely measured cardio-metabolic factors were extracted from the Clinical Practice Research Datalink. Multivariable multilevel piecewise and non-piecewise growth curve models assessed retrospective trajectories of cardio-metabolic factors by dementia status from up to 19 years preceding dementia diagnosis (dementia) or last contact with healthcare (no dementia). 23,546 patients developed dementia; mean (SD) follow-up was 10.0 (5.8) years. In the dementia group, mean systolic blood pressure increased 16-19 years before dementia diagnosis compared with patients without dementia, but declined more steeply from 16 years before diagnosis, while diastolic blood pressure generally declined at similar rates. Mean body mass index followed a steeper non-linear decline from 11 years before diagnosis in the dementia group. Mean blood lipid levels (total cholesterol, LDL, HDL) and glycaemic measures (fasting plasma glucose and HbA1c) were generally higher in the dementia group compared with those without dementia and followed similar patterns of change. However, absolute group differences were small. Differences in levels of cardio-metabolic factors were observed up to two decades prior to dementia diagnosis. Our findings suggest that a long follow-up is crucial to minimise reverse causation arising from changes in cardio-metabolic factors during preclinical dementia. Future investigations which address associations between cardiometabolic factors and dementia should account for potential non-linear relationships and consider the timeframe when measurements are taken.
Identifiants
pubmed: 36869989
doi: 10.1007/s10654-023-00977-7
pii: 10.1007/s10654-023-00977-7
pmc: PMC10276060
doi:
Substances chimiques
Blood Glucose
0
Cholesterol, HDL
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
733-744Subventions
Organisme : Diabetes UK
ID : 18/0005851
Pays : United Kingdom
Informations de copyright
© 2023. The Author(s).
Références
Arch Neurol. 2007 Jan;64(1):103-7
pubmed: 17210816
Nat Rev Neurol. 2019 Jan;15(1):11-24
pubmed: 30532084
Diabetes Care. 2015 Oct;38(10):1868-75
pubmed: 26216873
Nat Rev Endocrinol. 2018 Oct;14(10):591-604
pubmed: 30022099
Alzheimers Res Ther. 2017 Feb 6;9(1):7
pubmed: 28162091
Aging Dis. 2012 Dec;3(6):454-64
pubmed: 23251851
Lancet Diabetes Endocrinol. 2014 Mar;2(3):246-55
pubmed: 24622755
Aging Ment Health. 2011 Nov;15(8):978-84
pubmed: 21777080
JAMA Psychiatry. 2018 Oct 1;75(10):1033-1042
pubmed: 30043038
Cochrane Database Syst Rev. 2017 Jun 15;6:CD003804
pubmed: 28617932
Lancet Diabetes Endocrinol. 2013 Nov;1(3):183-90
pubmed: 24622366
Geriatr Gerontol Int. 2012 Apr;12 Suppl 1:103-9
pubmed: 22435945
Lancet Neurol. 2011 Nov;10(11):969-77
pubmed: 21958949
Emerg Themes Epidemiol. 2016 Oct 28;13:11
pubmed: 27800007
Alzheimers Dement. 2018 Feb;14(2):178-186
pubmed: 28943197
Alzheimers Res Ther. 2015 Jun 10;7(1):46
pubmed: 26060511
Int J Epidemiol. 2015 Jun;44(3):827-36
pubmed: 26050254
Curr Aging Sci. 2020;13(1):42-51
pubmed: 31530269
Lancet. 2020 Aug 8;396(10248):413-446
pubmed: 32738937
Lancet Diabetes Endocrinol. 2020 Jun;8(6):535-545
pubmed: 32445740
J Am Geriatr Soc. 2017 May;65(5):966-972
pubmed: 28067945
Eur J Pharmacol. 2008 May 6;585(1):97-108
pubmed: 18395201
Diabetes Care. 2008 Nov;31(11):2103-7
pubmed: 18650375
Neurology. 2007 Aug 21;69(8):739-46
pubmed: 17709705
BMJ Open. 2020 Nov 14;10(11):e038753
pubmed: 33191253
Hypertension. 2022 Jan;79(1):218-229
pubmed: 34775786
Diabetologia. 2017 Jan;60(1):69-80
pubmed: 27766347
Diabetes Care. 2016 Feb;39(2):300-7
pubmed: 26681727
Hypertension. 2012 Apr;59(4):796-801
pubmed: 22331381
Diabetes Res Clin Pract. 2015 Jun;108(3):e63-6
pubmed: 25799080
Nat Rev Neurol. 2018 Mar;14(3):168-181
pubmed: 29377010
Diabetes Care. 2021 Jul;44(7):1556-1563
pubmed: 34035076
Diabetologia. 2008 Feb;51(2):241-8
pubmed: 18060658
Diabetes Metab Res Rev. 2009 Oct;25(7):657-64
pubmed: 19768735
JAMA Intern Med. 2014 Mar;174(3):324-33
pubmed: 24493100
Lancet Diabetes Endocrinol. 2015 Jan;3(1):75-89
pubmed: 25163604
Arch Neurol. 2005 Jan;62(1):55-60
pubmed: 15642850